Skip to main content

Inclusion of Pregnant and Lactating Persons in Clinical Trials - A Workshop

Completed

This public workshop enabled stakeholders to examine the current state of evidence for drug products used by pregnant and lactating persons, and discussed the barriers and opportunities for including these populations in clinical trials. It provided a foundation for a now completed consensus study on this topic, which was requested by Congress in the Consolidated Appropriations Act, 2022.

Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.